Governing Risk, Engaging Publics, and Engendering Trust: New Horizons for Law and Social Science?

Modern biosciences require governance frameworks capable of simultaneously managing risk, coping with uncertainty, combatting ambivalence, and building trust, while encouraging the delivery of those instrumental outputs that we value/demand. This multi-dimensional task makes the design and delivery of good governance frameworks extremely difficult. Efforts to date have, by and large, failed, particularly where the law has been relied on. Preoccupation with risk has tended to shape regulatory systems, but the conception of risk relied on is deficient, and its use is often oriented to support precautionary approaches in the absence of 'evidence'. Our collaborative efforts lead us to suggest that more robust mechanisms need to be deployed which reveal and promote interactions with a fuller gamut of risks. We argue for a reflexive mode of governance which addresses the dynamic nature of science and uses the law more effectively as a value- and institution-framing mechanism. Copyright The Author 2013. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com, Oxford University Press.

[1]  S. Funtowicz,et al.  Science for the PostNormal Age , 2001 .

[2]  G. Laurie Reflexive governance in biobanking: on the value of policy led approaches and the need to recognise the limits of law , 2011, Human Genetics.

[3]  G. Laurie,et al.  Information Governance of Use of Health-Related Data in Medical Research in Scotland: Current Practices and Future Scenarios , 2011 .

[4]  Vicki Stone,et al.  Toxicology of nanoparticles: A historical perspective , 2007 .

[5]  Graeme Hodge,et al.  A Big Regulatory Tool-Box for a Small Technology , 2008 .

[6]  Gill Haddow,et al.  Generation Scotland: consulting publics and specialists at an early stage in a genetic database's development , 2008 .

[7]  S. Harmon Semantic, Pedantic or Paradigm Shift? Recruitment, Retention and Property in Modern Population Biobanking , 2009, European Journal of Health Law.

[8]  Helge Toutenburg,et al.  The Social Control of Technology , 1982 .

[9]  T. Faunce,et al.  Sunscreen Safety: The Precautionary Principle, The Australian Therapeutic Goods Administration and Nanoparticles in Sunscreens , 2008 .

[10]  B. Wynne Uncertainty and environmental learning: reconceiving science and policy in the preventive paradigm. , 1992 .

[11]  Steve Clarke,et al.  Future Technologies, Dystopic Futures and the Precautionary Principle , 2005, Ethics and Information Technology.

[12]  John Grin,et al.  Contextualizing Reflexive Governance: the Politics of Dutch Transitions to Sustainability , 2007 .

[13]  A. Nordmann If and Then: A Critique of Speculative NanoEthics , 2007, The Ethics of Nanotechnology, Geoengineering and Clean Energy.

[14]  S. Rayner,et al.  Human choice and climate change , 1998 .

[15]  M. Korstanje The Risk Society: Towards a new modernity , 2009 .

[16]  A. Kerr,et al.  On Ambivalence and Risk: Reflexive Modernity and the New Human Genetics , 2000 .

[17]  Kenneth W. Abbott,et al.  Risk Management Principles for Nanotechnology , 2007 .

[18]  A. Giddens The consequences of modernity , 1990 .

[19]  Shawn Harmon,et al.  Foresighting Futures: Law, New Technologies, and the Challenges of Regulating for Uncertainty , 2012 .

[20]  Arie Rip,et al.  Nano-ethics as NEST-ethics: Patterns of Moral Argumentation About New and Emerging Science and Technology , 2007 .

[21]  Daniel J. Fiorino Citizen Participation and Environmental Risk: A Survey of Institutional Mechanisms , 1990 .

[22]  R. Handy,et al.  Toxic effects of nanoparticles and nanomaterials: Implications for public health, risk assessment and the public perception of nanotechnology , 2007 .

[23]  James Wilsdon,et al.  See-Through Science : Why Public Engagement Needs to Move Upstream , 2004 .

[24]  Pratim Biswas,et al.  Assessing the risks of manufactured nanomaterials. , 2006, Environmental science & technology.

[25]  Graeme Laurie,et al.  Tackling community concerns about commercialisation and genetic research: a modest interdisciplinary proposal. , 2007, Social science & medicine.

[26]  Susan M. C. Gibbons Are UK genetic databases governed adequately? A comparative legal analysis , 2007, Legal Studies.

[27]  Raymond C Tallis,et al.  Hippocratic oaths: medicine and its discontents. , 2004, Clinical medicine.

[28]  René Crevel,et al.  Risk Management ‐ The Principles , 2009 .